Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
PALI
#4213
Palisade Bio, Inc. Common Stock
1.940
0
USD
-4.43%
Sektor:
Gesundheitswesen
Basis:
USD
Gewinnwährung:
USD
Tagesspanne
Jahresspanne
Tagesänderung
-4.43%
Monatliche Änderung
+14.12%
6 month change
+14.12%
Jahresänderung
+14.12%
Vorheriger Schlusskurs
2.030
0
Open
1.940
0
Bid
1.940
0
Ask
1.943
0
Low
1.940
0
High
1.940
0
Volumen
48
Märkte
Aktien
Gesundheitswesen
PALI
Open full chart
Financials
Overview
Finanzbericht
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
23.06 K
24.31 K
300.27 K
851.4 K
4.4 M
—
Valuation ratios
Enterprise value
—
—
—
—
-2.56 M
117.13 M
Price to earnings ratio
—
—
—
—
-0.16
-1.2
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
0.19
0.72
Price to book ratio
—
—
—
—
0.31
0.52
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
1.25
2.13
0.9
0.88
1.33
1.41
Return on equity %
1.67
3.61
1.14
1.09
1.93
2.82
Return on invested capital %
2 774.57
17.62 K
4 918.58
2 935.43
3 887.25
—
Gross margin %
100
100
—
100
—
—
Operating margin %
78.96 K
15 K
—
5 228
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
120.32 K
9 539.78
—
4 920
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
4.02
4.96
4.89
5.15
3.24
9.67
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0.02
0
0.02
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0
-0.01
-0.01
-0.01
-0.15
Long term debt to total equity ratio
—
0
-0.01
-0.01
-0.01
-0.33
Per share metrics
Operating cash flow per share
—
1 185.26
227.65
24.41
8.61
3.17
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
842.43
211.29
27.19
6.92
10.46
Net current asset value per share
—
992.79
251.04
29.23
7.41
11.59
Tangible book value per share
—
590.74
212.6
24.8
5.29
7.51
Working capital per share
—
792.53
199.72
23.56
5.12
7.29
Book value per share
—
590.74
212.6
24.8
5.29
7.51
Nachrichten
Stifel startet Coverage für Palisade Bio mit Kaufempfehlung wegen Medikament gegen Darmerkrankungen
Stifel initiates Palisade Bio stock with buy rating on IBD drug
Palisade Bio präsentiert positive Studiendaten zu Colitis-ulcerosa-Wirkstoff
Palisade Bio presents ulcerative colitis drug trial data at ECCO
Palisade Bio verstärkt klinischen Beirat mit CED-Spezialisten für Phase-2-Studie
Palisade Bio appoints IBD expert to clinical advisory board
Palisade Bio beruft zwei renommierte CED-Experten in den klinischen Beirat
Palisade Bio appoints two IBD experts to clinical advisory board
Palisade Bio: Direktor Williams kauft Aktien im Wert von 9.400 $
Palisade Bio director Williams buys $9,400 in shares
B.Riley startet Coverage für Palisade Bio mit "Buy"-Rating und Kursziel von 7,00 $
B.Riley initiates coverage on Palisade Bio stock with Buy rating